Arcus Biosciences (RCUS) Chief Medical Officer Move to Gilead (GILD) Suggests Strengthened Relationship Between the Companies - Mizuho

Go back to Arcus Biosciences (RCUS) Chief Medical Officer Move to Gilead (GILD) Suggests Strengthened Relationship Between the Companies - Mizuho
Gilead Sciences (NASDAQ: GILD) Delayed: 138.14 --0 (-0%)
Previous Close $138.14    52 Week High $108.63 
Open $138.14    52 Week Low $71.39 
Day High $138.14    P/E 76.32 
Day Low $138.14    EPS $1.81 
Volume 582       

(NYSE: RCUS) Delayed: 28.86 --0 (-0%)
Previous Close $28.86    52 Week High
Open $28.86    52 Week Low
Day High $28.86    P/E N/A 
Day Low $28.86    EPS
Volume 4,704